Form 4: Omada Health Director Receives RSU Grant

Jeryl L. Hilleman, a director at Omada Health, Inc., acquired 1,126 restricted stock units as part of the company's non-employee director compensation program.

Summary

• Jeryl L. Hilleman, a Director of Omada Health, Inc. (OMDA), acquired 1,126 shares of Common Stock.
• The acquisition occurred on October 5, 2025, and represents Restricted Stock Units (RSUs) granted at a price of $0 per share.
• These RSUs were granted pursuant to the Issuer's Non-Employee Director Compensation Program in lieu of retainer fees.
• Each RSU represents the right to receive one share of Common Stock, with settlement details governed by the Program.
• Following this transaction, Jeryl L. Hilleman beneficially owns 11,238 shares of Common Stock.

Sentiment

Score: 5

Explanation: The filing reports a routine equity compensation grant to a director, which is a neutral event in terms of immediate company performance or outlook.

Positives

• The grant of Restricted Stock Units aligns the director's interests with those of shareholders, incentivizing long-term company performance.
• The transaction is part of a structured Non-Employee Director Compensation Program, indicating a formal governance framework for director remuneration.

Negatives

• The issuance of 1,126 new shares (upon settlement of RSUs) will result in minor dilution for existing shareholders.

Related Party Transactions

• Jeryl L. Hilleman, a director, received 1,126 Restricted Stock Units as compensation under the Non-Employee Director Compensation Program.

Stakeholder Impact

• Shareholders: Minor potential dilution upon RSU settlement, but also increased alignment of director's interests with shareholder value.
• Management: The compensation program supports attracting and retaining qualified non-employee directors.

Next Steps

• Settlement of the Restricted Stock Units (RSUs) will occur on a date selected by the Reporting Person or as otherwise provided by the Non-Employee Director Compensation Program.

Key Dates

Keywords

Omada Health, OMDA, Form 4, SEC filing, insider transaction, restricted stock units, RSU, director compensation, equity grant, Jeryl L. Hilleman